Skip to main content
SpringerLink
Log in
Book cover

Acneiform Eruptions in Dermatology pp 329–341Cite as

Seborrheic Dermatitis

  • Chapter
  • First Online:

  • 1748 Accesses

Abstract

Seborrheic dermatitis is a chronic inflammatory papulosquamous skin condition that commonly involves the sebum-rich areas of the scalp, ears, face, chest, and skinfolds. It typically has a chronic, relapsing course that can range in severity from asymptomatic dandruff of the scalp to extensive skin involvement resulting in exfoliative erythroderma. Patients are otherwise healthy, but it has been noted to be a marker for human immunodeficiency virus (HIV) infection as well as some neurologic diseases. It is thought to be linked to a reaction to Malassezia furfur (Pityrosporum ovale), but the relationship is complex.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Elish D, Silverberg N. Infantile seborrheic dermatitis. Cutis. 2006;77:297–300.

    PubMed  Google Scholar 

  2. Foley P, Zuo Y, Plunkett A, Merlin K, Marks R. The frequency of common skin conditions in preschool-aged children in Australia. Arch Dermatol. 2003;139:318–22.

    Article  PubMed  Google Scholar 

  3. Gupta AK, Bluhm R. Seborrheic dermatitis. J Eur Acad Dermatol Venereol. 2004;28:13–26.

    Article  Google Scholar 

  4. Bikowski J. Facial seborrheic dermatitis: a report on current status and therapeutic horizons. J Drugs Dermatol. 2009;8:125–33.

    PubMed  Google Scholar 

  5. Mahe A, Simon F, Coulibaly S, Tounkara A, Bobin P. Predictive value of seborrheic dermatitis and other common dermatoses for HIV infection in Bamako Mali. J Am Acad Dermatol. 1996;34:1084–6.

    Article  PubMed  CAS  Google Scholar 

  6. Coopman SA, Johnson RA, Platt R, Stern RS. Cutaneous disease and drug reactions in HIV infection. N Engl J Med. 1993;328:1670–4.

    Article  PubMed  CAS  Google Scholar 

  7. Berger RS, Stoner MF, Hobbs ER, Hayes TJ, Boswell RN. Cutaneous manifestations of early human immunodeficiency virus exposure. J Am Acad Dermatol. 1988;19:298–303.

    Article  PubMed  CAS  Google Scholar 

  8. Coldiron BM, Bergstresser PR. Prevalence and clinical spectrum of skin disease in patients infected with human immunodeficiency virus. Arch Dermatol. 1989;125:357–61.

    Article  PubMed  CAS  Google Scholar 

  9. Mathes BM, Douglass MC. Seborrheic dermatitis in patients with acquired immunodeficiency syndrome. J Am Acad Dermatol. 1985;13:947–51.

    Article  PubMed  CAS  Google Scholar 

  10. Kohn SR, Pochi PE, Strauss JS, Sax DS, Feldman RG, Timberlake WH. Sebaceous gland secretion in Parkinson’s disease during L-DOPA treatment. J Invest Dermatol. 1973; 60:134–6.

    Article  PubMed  CAS  Google Scholar 

  11. Binder RL, Jonelis FJ. Seborrheic dermatitis in neuroleptic-induced parkinsonism. Arch Dermatol. 1983;119:473–5.

    Article  PubMed  CAS  Google Scholar 

  12. Maietta G, Fornaro P, Rongioletti F, Reobra A. Patients with mood depression have a high prevalence of seborrheic dermatitis. Acta Derm Venereol. 1990;70:432–4.

    PubMed  CAS  Google Scholar 

  13. Rocha N, Velho G, Horta M, Martins A, Massa A. Cutaneous manifestations of familial amyloidotic polyneuropathy. J Eur Acad Dermatol Venereol. 2005;19:605–7.

    Article  PubMed  CAS  Google Scholar 

  14. Barankin B, Guenther L. Dermatological manifestations of Down’s syndrome. J Cutan Med Surg. 2001;5:289–93.

    Article  PubMed  CAS  Google Scholar 

  15. Ercis M, Balci S, Atakan N. Dermatological manifestations of 71 Down syndrome children admitted to a clinical genetics unit. Clin Genet. 1996;50:317–20.

    PubMed  CAS  Google Scholar 

  16. Berg M. Epidemiological studies of the influence of sunlight on the skin. Photodermatol. 1989;6:80–4.

    PubMed  CAS  Google Scholar 

  17. Banerjee S, Gangopadhyay DN, Jana S, Chanda M. Seasonal variation in pediatric dermatoses. Indian J Dermatol. 2010;55:44–6.

    Article  PubMed  Google Scholar 

  18. Moehrle M, Dennenmoser B, Schalagenhauff B, Thomma S, Garbe C. High prevalence of seborrheic dermatitis on the face and scalp in mountain guides. Dermatology. 2000; 201:146–7.

    Article  PubMed  CAS  Google Scholar 

  19. Tegner E. Seborrheic dermatitis of the face induced by PUVA treatment. Acta Derm Venereol. 1983;63:335–9.

    PubMed  CAS  Google Scholar 

  20. Pirkhammer D, Seeber A, Honigsmann H, Tanew A. Narrow-band ultraviolet B (TL-01) phototherapy is an effective and safe treatment option for patients with severe seborrheic dermatitis. Br J Dermatol. 2000;143:964–8.

    Article  PubMed  CAS  Google Scholar 

  21. Burton JL, Pye RJ. Seborrhoea is not a feature of seborrheic dermatitis. Br Med J. 1983;286:1169–70.

    Article  CAS  Google Scholar 

  22. Naldi L, Rebora A. Seborrheic dermatitis. N Eng J Med. 2009;360:387–96.

    Article  CAS  Google Scholar 

  23. McGinely KJ, Leyden JJ, Marples RR, Kligman AM. Quantitative microbiology of the scalp in non-dandruff, dandruff, and seborrheic dermatitis. J Invest Dermatol. 1975;64:401–5.

    Article  Google Scholar 

  24. Whitlock FA. Pityrosporum ovale and some scaly conditions of the scalp. Br Med J. 1953;1:484–7.

    Article  PubMed  CAS  Google Scholar 

  25. Leyden JJ, McGinely KJ, Kligman AM. Role of microorganisms in dandruff. Arch Dermatol. 1976;112:333–8.

    Article  PubMed  CAS  Google Scholar 

  26. Carr MM, Pryce DM, Ive FA. Treatment of seborrhoeic dermatitis with ketoconazole: I. Response of seborrhoeic dermatitis of the scalp to topical ketoconazole. Br J Dermatol. 1987;116:213–6.

    Article  PubMed  CAS  Google Scholar 

  27. DeAngelis YM, Gemmer CM, Kaczvinsky JR, Kenneally DC, Schwartz JR, Dawson Jr TL. Three etiologic facets of dandruff and seborrheic dermatitis: Malassezia fungi, sebaceous lipids, and individual sensitivity. J Investig Dermatol Symp Proc. 2005;10:295–7.

    Article  PubMed  Google Scholar 

  28. DeAngelis YM, Saudners CW, Johnstone KR, Reeder NL, Coleman CG, Kaczvinsky JR, et al. Isolation and expression of a Malassezia globosa lipase gene, LIP1. J Invest Dermatol. 2007;127:2138–46.

    Article  PubMed  CAS  Google Scholar 

  29. Xu J, Saunders CW, Hu P, Grant RA, Boekhout T, Kuramae EE, et al. Dandruff-associated Malassezia genomes reveal convergent and divergent virulence traits shared with plant and human fungal pathogens. Proc Natl Acad Sci USA. 2007;104:18730–5.

    Article  PubMed  CAS  Google Scholar 

  30. Thomas DS, Ingham E, Bojar RA, Holland KT. In vitro modulation of human keratinocyte pro-and anti-inflammatory cytokine production by the capsule of Malassezia species. FEMS Immunol Med Microbiol. 2008;54:203–14.

    Article  PubMed  CAS  Google Scholar 

  31. Faergemann J, Bergbrant IM, Dohse M, Scott A, Westgate G. Seborrhoeic dermatitis and Pityrosporum (Malassezia) folliculitis: characterization of inflammatory cells and mediators in the skin by immunohistochemistry. Br J Dermatol. 2001;144:549–56.

    Article  PubMed  CAS  Google Scholar 

  32. Kim GW, Jung HJ, Ko HC, Kim MB, Lee WJ, Lee SJ, et al. Dermoscopy can be useful in differentiating scalp psoriasis from seborrheic dermatitis. Br J Dermatol. 2011;164:652–6.

    Article  PubMed  Google Scholar 

  33. Pinkus H, Mehregan AH. The primary histologic lesion of seborrheic dermatitis and psoriasis. J Invest Dermatol. 1965;46:109–16.

    Google Scholar 

  34. Skinner Jr RB, Noah PW, Taylor RM, Zanolli MD, West S, Guin JD, et al. Double-blind treatment of Seborrheic dermatitis with 2% ketoconazole cream. J Am Acad Dermatol. 1985;12:852–6.

    Article  PubMed  Google Scholar 

  35. Elewski B, Ling MR, Phillips TJ. Efficacy and safety of a new once-daily topical ketoconazole 2% gel in the treatment of seborrheic dermatitis: a phase III trial. J Drugs Dermatol. 2006;5:646–50.

    PubMed  Google Scholar 

  36. Elewski BE, Abramovits W, Kempers S, Schlessinger J, Rosen T, Gupta AK, et al. A novel foam formulation of ketoconazole 2% for the treatment of seborrheic dermatitis on multiple body regions. J Drugs Dermatol. 2007;6:1001–8.

    PubMed  Google Scholar 

  37. Faergemann J. Treatment of seborrhoeic dermatitis of the scalp with ketoconazole shampoo. A double-blind study. Acta Derm Venereol. 1990;70:171–2.

    PubMed  CAS  Google Scholar 

  38. Apasrawirote W, Udompataikul M, Rattanamongkolgul S. Topical antifungal agents for seborrheic dermatitis: systematic review and meta-analysis. J Med Assoc Thai. 2011;94:756–60.

    PubMed  Google Scholar 

  39. Segal R, David M, Ingber A, Lurie R, Sandbank M. Treatment with bifonazole shampoo for seborrhea and seborrheic dermatitis: a randomized, double-blind study. Acta Derm Venereol. 1992;72:454–5.

    PubMed  CAS  Google Scholar 

  40. Zienicke H, Korting HC, Braun-Falco O, Effendy I, Hagedorn M, Küchmeister B, et al. Comparative efficacy and safety of bifonazole 1% cream and the corresponding base preparation in the treatment of seborrhoeic dermatitis. Mycoses. 1993;36:325–31.

    Article  PubMed  CAS  Google Scholar 

  41. Shemer A, Nathansohn N, Kaplan B, Weiss G, Newman N, Trau H. Treatment of scalp seborrheic dermatitis and psoriasis with an ointment of 40% urea and 1% bifonazole. Int J Dermatol. 2000;39:532–4.

    Article  PubMed  CAS  Google Scholar 

  42. Abrams BB, Hänel H, Hoehler T. Ciclopirox olamine: a hydroxypyridone antifungal agent. Clin Dermatol. 1991;9:471–7.

    Article  PubMed  CAS  Google Scholar 

  43. Lebwohl M, Plott T. Safety and efficacy of ciclopirox 1% shampoo for the treatment of seborrheic dermatitis of the scalp in the US population: results of a double-blind, vehicle-controlled trial. Int J Dermatol. 2004;43:17–20.

    Article  PubMed  CAS  Google Scholar 

  44. Dupuy P, Maurette C, Amoric JC, Chosidow O, Study Investigator Group. Randomized, placebo-controlled, double-blind study on clinical efficacy of ciclopiroxolamine 1% cream in facial seborrhoeic dermatitis. Br J Dermatol. 2001;144:1033–7.

    Article  PubMed  CAS  Google Scholar 

  45. Shuster S, Meynadier J, Kerl H, Nolting S. Treatment and prophylaxis of seborrheic dermatitis of the scalp with antipityrosporal 1% ciclopirox shampoo. Arch Dermatol. 2005;141:47–52.

    Article  PubMed  CAS  Google Scholar 

  46. Chosidow O, Maurette C, Dupuy P. Randomized, open-labeled, non-inferiority study between ciclopiroxolamine 1% cream and ketoconazole 2% foaming gel in mild to moderate facial seborrheic dermatitis. Dermatology. 2003;203:233–40.

    Article  Google Scholar 

  47. Ratnavel RC, Squire RA, Boorman GC. Clinical efficacies of shampoos containing ciclopirox olamine (1.5%) and ketoconazole (2.0%) in the treatment of seborrhoeic dermatitis. J Dermatolog Treat. 2007;18:88–96.

    Article  PubMed  CAS  Google Scholar 

  48. Danby FW, Maddin WS, Margesson LJ, Rosenthal D. A randomized, double-blind, placebo-controlled trial of ketoconazole 2% shampoo versus selenium sulfide 2.5% shampoo in the treatment of moderate to severe dandruff. J Am Acad Dermatol. 1993;29:1008–12.

    Article  PubMed  CAS  Google Scholar 

  49. Prevost N, English 3rd JC. Xanthotrichia (yellow hair) due to selenium sulfide and dihydroxyacetone. J Drugs Dermatol. 2008;7:689–91.

    PubMed  Google Scholar 

  50. Piérard-Franchimont C, Goffin V, Decroix J, Piérard GE. A multicenter randomized trial of ketoconazole 2% and zinc pyrithione 1% shampoos in severe dandruff and seborrheic dermatitis. Skin Pharmacol Appl Skin Physiol. 2002;15:434–41.

    Article  PubMed  Google Scholar 

  51. Lorette G, Ermosilla V. Clinical efficacy of a new ciclopiroxolamine/zinc pyrithione shampoo in scalp seborrheic dermatitis treatment. Eur J Dermatol. 2006;16:558–64.

    PubMed  Google Scholar 

  52. Satchell AC, Saurajen A, Bell C, Barnetson RS. Treatment of dandruff with 5% tea tree oil shampoo. J Am Acad Dermatol. 2002;47:852–5.

    Article  PubMed  Google Scholar 

  53. Parsad D, Pandhi R, Negi KS, Kumar B. Topical metronidazole in seborrheic dermatitis—a double-blind study. Dermatology. 2001;202:35–7.

    Article  PubMed  CAS  Google Scholar 

  54. Siadat AH, Iraji F, Shahmoradi Z, Enshaieh S, Taheri A. The efficacy of 1% metronidazole gel in facial seborrheic dermatitis: a double blind study. Indian J Dermatol Venereol Leprol. 2006;72:266–9.

    Article  PubMed  Google Scholar 

  55. Koca R, Altinyazar HC, Eştürk E. Is topical metronidazole effective in seborrheic dermatitis? A double-blind study. Int J Dermatol. 2003;42:632–5.

    Article  PubMed  CAS  Google Scholar 

  56. Ozcan H, Seyhan M, Yologlu S. Is metronidazole 0.75% gel effective in the treatment of seborrhoeic dermatitis? A double-blind, placebo controlled study. Eur J Dermatol. 2007;17:313–6.

    PubMed  CAS  Google Scholar 

  57. Seckin D, Gurbuz O, Akin O. Metronidazole 0.75% gel vs. ketoconazole 2% cream in the treatment of facial seborrheic dermatitis: a randomized, double-blind study. J Eur Acad Dermatol Venereol. 2007;21:345–50.

    Article  PubMed  CAS  Google Scholar 

  58. Stratigos JD, Antoniou C, Katsambas A, Böhler K, Fritsch P, Schmölz A, et al. Ketoconazole 2% cream versus hydrocortisone 1% cream in the treatment of seborrheic dermatitis. A double-blind comparative study. J Am Acad Dermatol. 1988;19:850–3.

    Article  PubMed  CAS  Google Scholar 

  59. Katsambas A, Antoniou C, Frangouli E, Avgerinou G, Michailidis D, Stratigos J. A double-blind trial of treatment of seborrhoeic dermatitis with 2% ketoconazole cream compared with 1% hydrocortisone cream. Br J Dermatol. 1989;121:353–7.

    Article  PubMed  CAS  Google Scholar 

  60. Ortonne JP, Lacour JP, Vitetta A, Le Fichoux Y. Comparative study of ketoconazole 2% foaming gel and betamethasone dipropionate 0.05% lotion in the treatment of seborrhoeic dermatitis in adults. Dermatology. 1992;184:275–80.

    Article  PubMed  CAS  Google Scholar 

  61. Ortonne JP, Nikkels AF, Reich K, Ponce Olivera RM, Lee JH, Kerrouche N, et al. Efficacious and safe management of moderate to severe scalp seborrhoeic dermatitis using clobetasol propionate shampoo 0·05% combined with ketoconazole shampoo 2%: a randomized, controlled study. Br J Dermatol. 2011;165:171–6.

    Article  PubMed  CAS  Google Scholar 

  62. Falk MS. Fluocinolone acetonide in propylene glycol. Arch Dermatol. 1963;88:928–9.

    Article  PubMed  CAS  Google Scholar 

  63. Kircik L. The evolving role of therapeutic shampoos for targeting symptoms of inflammatory scalp disorders. J Drugs Dermatol. 2010;9:41–8.

    PubMed  Google Scholar 

  64. Meshkinpour A, Sun J, Weinstein G. An open pilot study using tacrolimus ointment in the treatment of seborrheic dermatitis. J Am Acad Dermatol. 2003;49:145–7.

    Article  PubMed  Google Scholar 

  65. Braza TJ, DiCarlo JB, Soon SL, McCall CO. Tacrolimus 0.1% ointment for seborrhoeic dermatitis: an open-label pilot study. Br J Dermatol. 2003;148:1242–4.

    Article  PubMed  CAS  Google Scholar 

  66. Shin H, Kwon OS, Won CH, Kim BJ, Lee YW, Choe YB, et al. Clinical efficacies of topical agents for the treatment of seborrheic dermatitis of the scalp: a comparative study. J Dermatol. 2009;36:131–7.

    Article  PubMed  CAS  Google Scholar 

  67. Warshaw EM, Wohlhuter RJ, Liu A, Zeller SA, Wenner RA, Bowers S, et al. Results of a randomized, double-blind, vehicle-controlled efficacy trial of pimecrolimus cream 1% for the treatment of moderate to severe facial seborrheic dermatitis. J Am Acad Dermatol. 2007;57:257–64.

    Article  PubMed  Google Scholar 

  68. Rigopoulos D, Ioannides D, Kalogeromitros D, Gregoriou S, Katsambas A. Pimecrolimus cream 1% vs. betamethasone 17-valerate 0.1% cream in the treatment of seborrhoeic dermatitis. A randomized open-label clinical trial. Br J Dermatol. 2004;151:1071–5.

    Article  PubMed  CAS  Google Scholar 

  69. Ballanger F, Tenaud I, Volteau C, Khammari A, Dréno B. Anti-inflammatory effects of lithium gluconate on keratinocytes: a possible explanation for efficiency in seborrhoeic dermatitis. Arch Dermatol Res. 2008;300:215–23.

    Article  PubMed  CAS  Google Scholar 

  70. Efalith Multicenter Trial Group. A double-blind, placebo-controlled, multicenter trial of lithium succinate ointment in the treatment of seborrheic dermatitis. J Am Acad Dermatol. 1992;26:452–7.

    Article  Google Scholar 

  71. Dreno B, Moyse D. Lithium gluconate in the treatment of seborrhoeic dermatitis: a multicenter, randomised, double-blind study versus placebo. Eur J Dermatol. 2002;12:549–52.

    PubMed  CAS  Google Scholar 

  72. Dreno B, Chosidow O, Revuz J, Moyse D, Study Investigator Group. Lithium gluconate 8% vs ketoconazole 2% in the treatment of seborrhoeic dermatitis: a multicentre, randomized study. Br J Dermatol. 2003;148:1230–6.

    Article  PubMed  CAS  Google Scholar 

  73. Langtry JA, Rowland Payne CM, Staughton RC, Stewart JC, Horrobin DF. Topical lithium succinate ointment (Efalith) in the treatment of AIDS-related seborrhoeic dermatitis. Clin Exp Dermatol. 1997;22:216–9.

    Article  PubMed  CAS  Google Scholar 

  74. Davies DB, Boorman GC, Shuttleworth D. Comparative efficacy of shampoos containing coal tar (4.0% w/w; Tarmed), coal tar (4.0% w/w) plus ciclopirox olamine (1.0% w/w/; Tarmed) and ketoconazole 92.0% w/w/; Nizoral) for the treatment of dandruff/seborrheic dermatitis. J Deramtol Treat. 1999;10:177–83.

    Article  CAS  Google Scholar 

  75. Seite S, Rougier A, Talarico S. Randomized study comparing the efficacy and tolerance of a lipohydroxy acid shampoo to a ciclopiroxolamine shampoo in the treatment of scalp seborrheic dermatitis. J Cosmet Dermatol. 2009;8:249–53.

    Article  PubMed  Google Scholar 

  76. Veraldi S, Menter A, Innocenti M. Treatment of mild to moderate seborrhoeic dermatitis with MAS064D (Sebclair), a novel topical medical device: results of a pilot, randomized, double-blind, controlled trial. J Eur Acad Dermatol Venereol. 2008;22:290–6.

    Article  PubMed  CAS  Google Scholar 

  77. Ionescu MA, Baroni A, Brambilla L, Cannavò SP, Cristaudo A, Vedove CD, et al. Double blind clinical trial in a series of 115 patients with seborrheic dermatitis: prevention of relapses using a topical modulator of Toll like receptor 2. G Ital Dermatol Venereol. 2011;146:185–9.

    PubMed  CAS  Google Scholar 

  78. Ryu S, Choi SY, Acharya S, Chun YJ, Gurley C, Park Y, et al. Antimicrobial and anti-inflammatory effects of cecropin A(1–8)-magainin2(1–12) hybrid peptide analog P5 against Malassezia furfur infection in human keratinocytes. J Invest Dermatol. 2011;131:1677–83.

    Article  PubMed  CAS  Google Scholar 

  79. Shemer A, Kaplan B, Nathansohn N, Grunwald MH, Amichai B, Trau H. Treatment of moderate to severe facial seborrheic dermatitis with itraconazole: an open non-comparative study. Isr Med Assoc J. 2008;10:417–8.

    PubMed  Google Scholar 

  80. Kose O, Erbil H, Gur AR. Oral itraconazole for the treatment of seborrhoeic dermatitis: an open, noncomparative trial. J Eur Acad Dermatol Venereol. 2005;19:172–5.

    Article  PubMed  CAS  Google Scholar 

  81. Baysal V, Yildirim M, Ozcanli C, Ceyhan AM. Itraconazole in the treatment of seborrheic dermatitis: a new treatment modality. Int J Dermatol. 2004;43:63–6.

    Article  PubMed  CAS  Google Scholar 

  82. Cömert A, Bekiroglu N, Gürbüz O, Ergun T. Efficacy of oral fluconazole in the treatment of seborrheic dermatitis: a placebo-controlled study. Am J Clin Dermatol. 2007;8:235–8.

    Article  PubMed  Google Scholar 

  83. Vena GA, Micali G, Santoianni P, Cassano N, Peruzzi E. Oral terbinafine in the treatment of multi-site seborrhoic dermatitis: a multicenter, double-blind placebo-controlled study. Int J Immunopathol Pharmacol. 2005;18:745–53.

    PubMed  CAS  Google Scholar 

  84. Pirkhammer D, Seeber A, Hönigsmann H, Tanew A. Narrow-band ultraviolet B (ATL-01) phototherapy is an effective and safe treatment option for patients with severe seborrhoeic dermatitis. Br J Dermatol. 2000;143:964–8.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, Henry Ford Health System, 6530 Farmington Road, West Bloomfield, MI, 48322, USA

    Elizabeth Farhat M.D. & Linda Stein Gold M.D.

Authors
  1. Elizabeth Farhat M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Linda Stein Gold M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Linda Stein Gold M.D. .

Editor information

Editors and Affiliations

  1. Mount Sinai Medical Center, New York, USA

    Joshua Zeichner

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media New York

About this chapter

Cite this chapter

Farhat, E., Gold, L.S. (2014). Seborrheic Dermatitis. In: Zeichner, J. (eds) Acneiform Eruptions in Dermatology. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-8344-1_46

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-8344-1_46

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-8343-4

  • Online ISBN: 978-1-4614-8344-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation